U.S. markets open in 1 hour 28 minutes
S&P Futures
4,110.00-10.25(-0.25%)Dow Futures
33,519.00-112.00(-0.33%)Nasdaq Futures
13,803.25-5.50(-0.04%)
Johnson & Johnson (JNJ)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
161.64+0.39 (+0.24%)
At close: 4:00PM EDT
157.60 -4.04 (-2.50%)
Pre-Market: 8:02AM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 161.25 |
| Open | 161.09 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's Range | 160.34 - 162.08 |
| 52 Week Range | 133.65 - 173.65 |
| Volume | 5,020,362 |
| Avg. Volume | 8,086,238 |
| Market Cap | 425.551B |
| Beta (5Y Monthly) | 0.72 |
| PE Ratio (TTM) | 29.34 |
| EPS (TTM) | 5.51 |
| Earnings Date | Apr 20, 2021 |
| Forward Dividend & Yield | 4.04 (2.51%) |
| Ex-Dividend Date | Feb 22, 2021 |
| 1y Target Est | 185.44 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-25% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- Editor's PickYahoo Finance
‘Unvaccinated folks’ are driving coronavirus surges as American society slowly reopens
It’s mainly the younger generations who are testing positive for the coronavirus, and health experts are attributing it to the fact that they are more likely to still be unvaccinated.
- Editor's PickYahoo Finance Video
Doctor on vaccine push: 'These vaccines work extremely well and that’s something to celebrate'
University of Alabama at Birmingham Associate Dean for Global Health Dr. Michael Saag joins Yahoo Finance Live to discuss the latest spike in COVID-19 cases.
- Investor's Business Daily
Is J&J Stock A Buy As Blood-Clot Question Clouds Its European Future?
Is JNJ stock a buy now that the Food and Drug Administration has authorized its one-shot coronavirus vaccine for emergency use? Shares are now forming a new chart pattern.
© 2021 Verizon Media. All rights reserved.
